Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads

Sarah Schroyen,1 Stéphane Adam,1 Guy Jerusalem,2,3 Pierre Missotten1 1University of Liège, Psychology of Aging Unit, 2University of Liège, Laboratory of Medical Oncology, 3CHU Sart Tilman Liege, Department of Medical Oncology, Liège, Belgium Abstract: Can...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Schroyen S, Adam S, Jerusalem G, Missotten P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Oncogeriatry clinical approaches stigmatization ageism Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/230569e95b2845c79c3942be11e8c748
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:230569e95b2845c79c3942be11e8c748
record_format	dspace
spelling	oai:doaj.org-article:230569e95b2845c79c3942be11e8c7482021-12-02T06:35:17ZAgeism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads1178-1998https://doaj.org/article/230569e95b2845c79c3942be11e8c7482014-12-01T00:00:00Zhttps://www.dovepress.com/ageism-and-its-clinical-impact-in-oncogeriatry-state-of-knowledge-and--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Sarah Schroyen,1 Stéphane Adam,1 Guy Jerusalem,2,3 Pierre Missotten1 1University of Liège, Psychology of Aging Unit, 2University of Liège, Laboratory of Medical Oncology, 3CHU Sart Tilman Liege, Department of Medical Oncology, Liège, Belgium Abstract: Cancer is a major health problem that is widespread in elderly people. Paradoxically, older people suffering from cancer are often excluded from clinical trials and are undertreated when compared to younger patients. One explanation for these observations is age stigma (ie, stereotypes linked to age, and thus ageism). These stigmas can result in deleterious consequences for elderly people’s mental and physical health in “normal” aging. What, then, is the impact in a pathological context, such as oncology? Moreover, health care professionals’ attitudes can be tainted with ageism, thus leading to undesirable consequences for patients. To counter these stigmas, we can apply some possible interventions emerging from research on normal aging and from social psychology, such as intergenerational contact, activation of positive stereotypes, self-affirmation, and so on; these tools can improve opinions of aging among the elderly people themselves, as well as health care professionals, thus affecting patients’ mental and physical health. Keywords: oncogeriatry, clinical approaches, stigmatization, ageismSchroyen SAdam SJerusalem GMissotten PDove Medical PressarticleOncogeriatryclinical approachesstigmatizationageismGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 117-125 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Oncogeriatry clinical approaches stigmatization ageism Geriatrics RC952-954.6
spellingShingle	Oncogeriatry clinical approaches stigmatization ageism Geriatrics RC952-954.6 Schroyen S Adam S Jerusalem G Missotten P Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
description	Sarah Schroyen,1 Stéphane Adam,1 Guy Jerusalem,2,3 Pierre Missotten1 1University of Liège, Psychology of Aging Unit, 2University of Liège, Laboratory of Medical Oncology, 3CHU Sart Tilman Liege, Department of Medical Oncology, Liège, Belgium Abstract: Cancer is a major health problem that is widespread in elderly people. Paradoxically, older people suffering from cancer are often excluded from clinical trials and are undertreated when compared to younger patients. One explanation for these observations is age stigma (ie, stereotypes linked to age, and thus ageism). These stigmas can result in deleterious consequences for elderly people’s mental and physical health in “normal” aging. What, then, is the impact in a pathological context, such as oncology? Moreover, health care professionals’ attitudes can be tainted with ageism, thus leading to undesirable consequences for patients. To counter these stigmas, we can apply some possible interventions emerging from research on normal aging and from social psychology, such as intergenerational contact, activation of positive stereotypes, self-affirmation, and so on; these tools can improve opinions of aging among the elderly people themselves, as well as health care professionals, thus affecting patients’ mental and physical health. Keywords: oncogeriatry, clinical approaches, stigmatization, ageism
format	article
author	Schroyen S Adam S Jerusalem G Missotten P
author_facet	Schroyen S Adam S Jerusalem G Missotten P
author_sort	Schroyen S
title	Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
title_short	Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
title_full	Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
title_fullStr	Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
title_full_unstemmed	Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
title_sort	ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/230569e95b2845c79c3942be11e8c748
work_keys_str_mv	AT schroyens ageismanditsclinicalimpactinoncogeriatrystateofknowledgeandtherapeuticleads AT adams ageismanditsclinicalimpactinoncogeriatrystateofknowledgeandtherapeuticleads AT jerusalemg ageismanditsclinicalimpactinoncogeriatrystateofknowledgeandtherapeuticleads AT missottenp ageismanditsclinicalimpactinoncogeriatrystateofknowledgeandtherapeuticleads
_version_	1718399798266036224

Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads

Ejemplares similares